Company: MYI
Filing Date: 2025-07-15
Form Type: 425
Source: 0001193125-25-159406
Chunk: 30

Company: BLACKROCK MUNIYIELD QUALITY FUND III, INC.
Filing Date: 2025-07-15
Form: 425
Chunk 30
---
 |      |                         | (13.96 | )% |     |     | (16.76 | )% |

| (1) | Based on the Fund’s computations. |

| (2) | Calculated based on the information presented. Percentages are rounded. |

On July 8, 2025, the NAV per Share was $7.21 and the last reported market price for a Share on the NYSE on such date was $6.58. During the pendency of the Offer, daily NAV quotations can be obtained in the manner indicated in Section 1. The tender of Shares, unless and until such tendered Shares are accepted for payment, will not affect the record ownership of any such tendered Shares for purposes of entitlement to any dividends payable by the Fund.

| 11. | Interests of Directors and Officers; Transactions and Arrangements Concerning the Shares |

Information, as of particular dates, concerning the Fund’s directors and executive officers, their remuneration, any material interest of such persons in transactions with the Fund and other matters, is required to be disclosed in proxy statements distributed to the Fund’s stockholders and filed with the Commission. The business address and business telephone number of each director and executive officer of the Fund are in care of BlackRock, Inc., 50 Hudson Yards, New York, NY 10001. As of February 28, 2025, none of the Fund’s directors beneficially owned any of the outstanding Shares of the Fund. To the best of the Fund’s knowledge, no executive officer of the Fund beneficially owned Shares of the Fund as of February 28, 2025. Except as set forth in this Offer to Purchase, to the best of the Fund’s knowledge, no person controlling the Fund or the Investment Advisor nor any associate or majority-owned subsidiary of such person beneficially owned Shares of the Fund as of February 28, 2025. None of the Fund, the Investment Advisor or, to the best of the Fund’s knowledge, any of the Fund’s directors or executive officers or any person controlling the Fund or the Investment Advisor, has effected any transaction in Shares during the 60 days prior to the date of this Offer to Purchase, except (i) for the issuance of Shares in the ordinary course of business (including dividend reinvestment) and (ii) in connection with the completion of the Fund’s tender offer that commenced on April 17, 2025 and expired on May 20, 2025, pursuant